August 21, 2024 by Wiley Credit: Pixabay/CC0 Public DomainA recent analysis of all relevant published studies reveals clear benefits of cognitive behavioral therapy (CBT) for improving mental health and quality of life in cancer survivors. The findings, which are published in Cancer Medicine, extend CBT’s effects beyond what has long been known in the general...
Category: <span>Psychology & Psychiatry</span>
ESMO: Combination therapy reduced agitated delirium in patients with advanced cancers
September 15, 2024 by University of Texas M. D. Anderson Cancer Center Credit: Unsplash/CC0 Public DomainTreatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD...
High doses of some prescription stimulants tied to increased psychosis risk
September 12, 2024 by McLean Hospital Credit: Unsplash/CC0 Public DomainPrescribing rates for stimulants that treat attention-deficit/hyperactivity disorder (ADHD) have increased significantly over the past decade, with some of the largest increases reported during the COVID-19 pandemic. A new study of adult emergency department admissions at Mass General Brigham, led by McLean Hospital researchers, found that...
Study shows psychotherapies prove successful in reducing suicide and self-injury attempts in youths
September 10, 2024 by Elsevier Credit: Pixabay from PexelsA study published in the Journal of the American Academy of Child & Adolescent Psychiatry, found that a high percentage of youth will experience periods of remission and recovery of suicide attempts during and after treatment with dialectical behavior therapy (DBT). Rates of remission and recovery were...
Unraveling schizophrenia: New insights into genetic and environmental interplay
September 10, 2024 by Genomic Press Credit: Pixabay/CC0 Public DomainIn the complex landscape of mental health research, a new viewpoint offers a critical examination of how genes and environment conspire to influence schizophrenia risk. Published in Genomic Psychiatry, this analysis by researchers Natassia Robinson and Sarah E. Bergen from Karolinska Institutet in Stockholm, Sweden, brings...
“Out-of-body” research could lead to new ways to promote social harmony
News Release 9-Sep-2024 Peer-Reviewed PublicationUniversity of Virginia Health System image: Fascinating new work by the University of Virginia School of Medicine’s Marina Weiler, PhD, and colleagues explores the complex relationship between altered states of consciousness and empathy. Credit: UVA Health Out-of-body experiences, such as near-death experiences, can have a “transformative” effect on people’s ability to...
RNA treatment shows promise for enhancing memory and reducing anxiety
September 5, 2024 by Genomic Press Targeting strategy to knock down the mouse HTR2A gene using shRNA and transduction efficiency in primary mouse cortical neurons. Credit: Genomic Psychiatry (2024). DOI: 10.61373/gp024r.0043Scientists at Cognigenics have made a significant advance in the field of neuroscience and mental health treatment. Their research, published in Genomic Psychiatry, demonstrates that...
Risky combinations of psychiatric drugs prescribed for young patients
September 5, 2024 by Rutgers University Credit: Pixabay/CC0 Public DomainA new study reveals that young patients treated with psychiatric medications receive potentially dangerous combinations with concerning frequency. Researchers from Rutgers Health and other institutions recently analyzed New York State Medicaid records for more than 141,000 patients receiving any psychiatric medication. Nearly 400 of them had...
Researchers discover a mechanism that impairs synaptic plasticity in the brains of schizophrenia patients
News Release 4-Sep-2024 Peer-Reviewed PublicationTampere University A new study led by researchers at Tampere University has mapped genes linked to schizophrenia and uncovered a mechanism that disrupts synaptic plasticity in affected individuals. The researchers showed the role of three proteins in mediating the impairments of plasticity in schizophrenia. The findings may hold promise for the...
A new drug target for psychiatric disorders
News Release 4-Sep-2024 Misha Kudryshev’s lab at the Max Delbrück Center has identified a potentially new drug target for serotonin, which is involved in depression and schizophrenia Peer-Reviewed PublicationMax Delbrück Center for Molecular Medicine in the Helmholtz Association image: Researchers have identified an intermediate form of the 5-HT3A serotonin receptor (blue). In its final form,...